Hussain M, Lai AY, Franklin D, Lenz K, et al. Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease. Inflamm Bowel Dis 2026 Jun 27:izag101. doi: 10.1093.
PMID: 42364076